Literature DB >> 7532630

Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.

E A de Velasco1, D Merkus, S Anderton, A F Verheul, E F Lizzio, R Van der Zee, W Van Eden, T Hoffman, J Verhoef, H Snippe.   

Abstract

Improvement of antibody responses to polysaccharides through their linkage to proteins is thought to be mediated by protein-specific T helper (Th) cells. To investigate whether the carrier protein of a conjugate could be substituted by a Th epitope, Streptococcus pneumoniae type 17F polysaccharide (PS) was bromoacetylated and coupled to different peptides via their carboxy-terminal cysteines. Two peptides, one from the mycobacterial 65-kDa heat shock protein (hsp65) and the other from influenza virus hemagglutinin, are well-known Th epitopes. Two other peptides were selected from the pneumolysin sequence by Th epitope prediction methods; one of them was synthesized with cysteine either at the carboxy or the amino terminus. Three conjugates consistently elicited in mice anti-PS immunoglobulin M (IgM) and IgG responses that were not observed upon immunization with derivatized PS without peptide. The same conjugates induced no anti-PS antibody responses in athymic (nu/nu) mice, whereas clear responses were elicited in euthymic (nu/+) controls, demonstrating the thymus-dependent character of these conjugates. Only the three conjugates inducing anti-PS responses were capable of eliciting antipeptide antibodies. One of the immunogenic conjugates was studied in more detail. It induced significant protection and an anti-PS IgG response comprising all subclasses. On the basis of these results and proliferation studies with peptide and conjugate-primed cells, it is concluded that linkage of Th epitopes to PS in the right orientation enhances its immunogenicity in a thymus-dependent manner. Future possibilities for using peptides as carriers for inducing antibody responses to poorly immunogenic saccharide antigens are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532630      PMCID: PMC173096          DOI: 10.1128/iai.63.3.961-968.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Polysaccharide-protein conjugates: a new generation of vaccines.

Authors:  J B Robbins; R Schneerson
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

2.  The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes.

Authors:  J M van Noort; A C van der Drift
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

3.  Estimation of the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 by inhibition ELISA.

Authors:  G J van Dam; A F Verheul; G J Zigterman; M J de Reuver; H Snippe
Journal:  Mol Immunol       Date:  1989-03       Impact factor: 4.407

4.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

5.  Differential pattern of T cell recognition of the 65-kDa mycobacterial antigen following immunization with the whole protein or peptides.

Authors:  S J Brett; J R Lamb; J H Cox; J B Rothbard; A Mehlert; J Ivanyi
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

Review 6.  Synthetic peptide representing a T-cell epitope of CRM197 substitutes as carrier molecule in a Haemophilus influenzae type B (Hib) conjugate vaccine.

Authors:  G S Bixler; R Eby; K M Dermody; R M Woods; R C Seid; S Pillai
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

7.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

8.  Murine CD4+ T cell subsets defined.

Authors:  K Hayakawa; R R Hardy
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

9.  MHC control of CD4+ T cell subset activation.

Authors:  J S Murray; J Madri; J Tite; S R Carding; K Bottomly
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

2.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

3.  A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.

Authors:  P Chong; N Chan; A Kandil; B Tripet; O James; Y P Yang; S P Shi; M Klein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 4.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

Review 5.  New vaccines for the prevention of pneumococcal infections.

Authors:  H Käyhty; J Eskola
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.